Loading...
Novel challenges in spinal muscular atrophy – How to screen and whom to treat?
In recent years, disease‐modifying and life‐prolonging therapies for spinal muscular atrophy (SMA) have been developed. However, patients are currently diagnosed with significant delay and therapies are often administered in advanced stages of motor neuron degeneration, showing limited effects. Meth...
Saved in:
| Published in: | Ann Clin Transl Neurol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
John Wiley and Sons Inc.
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6331314/ https://ncbi.nlm.nih.gov/pubmed/30656198 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.689 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|